Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 11478737)

Published in Neurochem Res on February 01, 2001

Authors

K Y Vinod1, M N Subhash, B N Srinivas

Author Affiliations

1: Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Articles by these authors

Monitoring of serum lithium levels in manic depressive psychosis. Indian J Med Res (1980) 1.06

Homovanillic acid & 5-hydroxy indole acetic acid in the CSF in rheumatic chorea. Indian J Med Res (1983) 0.97

Evidence of linkage and association on 18p11.2 for psychosis. Am J Med Genet B Neuropsychiatr Genet (2006) 0.88

Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int (1994) 0.87

Hydroxyprolinemia: a case report. Indian Pediatr (1974) 0.84

Metabolic anomalies detected during a systematic biochemical screening of mentally retarded cases. Indian J Med Res (1977) 0.84

CSF amine metabolites in depression. Biol Psychiatry (1992) 0.84

Lithium toxicity at therapeutic serum levels. Br J Psychiatry (1993) 0.84

Effect of disulfiram administration on brain tryptophan, serotonin and peripheral tryptophan content. Neurochem Int (1993) 0.83

Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int (2007) 0.82

Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochem Res (1995) 0.82

Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain. Neurochem Int (2001) 0.80

Lamotrigine induced selective changes in 5-HT(1A) receptor mediated response in rat brain. Neurochem Int (2002) 0.79

Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine. Neurochem Res (1994) 0.78

Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites. Mov Disord (1993) 0.78

Differential modulation of α-1 adrenoceptor subtypes by antidepressants in the rat brain. J Neural Transm (Vienna) (2010) 0.78

Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. Bioorg Med Chem (2009) 0.77

Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy. Psychoneuroendocrinology (1997) 0.77

Role of glutathione reductase system in disulfiram conversion to diethyldithiocarbamate. Life Sci (1991) 0.77

Disulfiram lowers Ca2+, Mg(2+)-ATPase activity of rat brain synaptosomes. Neurochem Res (1994) 0.77

Differential effect of lithium on 5-HT1 receptor-linked system in regions of rat brain. Neurochem Int (1999) 0.77

Early onset Parkinson's disease: are juvenile- and young-onset different? Mov Disord (1994) 0.77

Multiple endocrine responses to clonidine in obsessive compulsive dissorder. Indian J Psychiatry (1992) 0.76

Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders. J Neural Transm Gen Sect (1992) 0.76

Study of pyruvate kinase activity in human astrocytomas - alanine-inhibition test revisted. Neurol India (2009) 0.76

Monoamine oxidase isoenzymes in rat brain: differential changes during postnatal development but not aging. Neurobiol Aging (1996) 0.76

Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models. Eur J Med Chem (2009) 0.75

CSF zinc in Alzheimer's type dementia. Biol Psychiatry (1988) 0.75

Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models. Bioorg Med Chem (2008) 0.75

Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. Bioorg Med Chem (2008) 0.75

Effect of amitriptyline on adrenergic receptor number and second messenger function in rat brain. Pak J Biol Sci (2012) 0.75

Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain. J Neural Transm (Vienna) (2000) 0.75

Increased acetylcholinesterase activity in selected regions of rat brain after chronic (-)-deprenyl administration. Neurochem Res (1996) 0.75

Lactate dehydrogenase isoenzyme patterns in human foetal tissues during development. Indian J Physiol Pharmacol (1987) 0.75

Biochemical screening in mental retardation. Indian J Pediatr (1982) 0.75

Erythrocyte lithium efflux in mania. Indian J Med Res (1981) 0.75

Biochemical screening and mental retardation. Indian J Pediatr (1983) 0.75

Histidinemia. Report of a case. Indian J Pediatr (1974) 0.75

Homocystinuria--a cause for stroke in young. J Assoc Physicians India (1986) 0.75

Effect of antidepressants on intracellular Ca++ mobilization in human frontal cortex. Biol Psychiatry (1998) 0.75

Alterations in 5-HT(1A) receptors and adenylyl cyclase response by trazodone in regions of rat brain. Life Sci (2002) 0.75

Phenylalanine tolerance test in parents of phenylketonurics. Acta Anthropogenet (1980) 0.75

Erythrocyte membrane Na-K ATPase activity in affective disorder. Biol Psychiatry (1989) 0.75

The effect of chronic chlorpromazine administration on monoamine levels in various regions of rat brain. Neurochem Res (1995) 0.75

Lithium excretion and therapeutic response in mania. Indian J Med Res (1981) 0.75

Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain. Neurochem Res (1998) 0.75

Additional phenytoin is frequently needed in patients undergoing craniotomy for supratentorial tumour. Eur J Anaesthesiol (2008) 0.75

Body weight--dose relationship of lithium carbonate in manics. Indian J Med Res (1981) 0.75